Health
Press release: Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia
Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia Untreated umbilical hernias occur in 20% of patients with ascites due to liver cirrhosis. Without treatment, there is a significant risk of complications that are life threatening and require emergency surgeryEffective management of ascites is necessary for elective surgical repair in such patientsThe team at Mayo Clinic, Arizona present a case report of a patient in the POSEIDON study that underwen
About this update from Sequana Medical N.v
[{"type":"image","alt":"Sequana Medical NV","displaySize":"","headline":null,"caption":"Sequana Medical NV","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":64,"url":"https://media.zenfs.com/en/globenewswire.com/eebd983759ebc3a966954513471e9960"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/I6pT.8uzi87Vh1qGIu6GAg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/eebd983759ebc3a966954513471e9960","width":300,"height":64}},"lazy":false},{"type":"text","content":"Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia","length":97,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Untreated umbilical hernias occur in 20% of patients with ascites due to liver cirrhosis. Without treatment, there is a significant risk of complications that are life threatening and require emergency surgery","length":209,"tagName":"p"}]},{"val":[{"type":"text","content":"Effective management of ascites is necessary for elective surgical repair in such patients","length":90,"tagName":"p"}]},{"val":[{"type":"text","content":"The team at Mayo Clinic, Arizona present a case report of a patient in the POSEIDON study that underwent a successful robotic hernia repair following control of their ascites with the alfapump","length":192,"tagName":"p"}]},{"val":[{"type":"text","content":"US commercial launch remains on track for this quarter through specialty commercial team focused on liver transplant centers","length":124,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":615,"olType":false},{"type":"text","content":"Ghent, Belgium – 31 July 2025 – Sequana Medical NV (Euronext Brussels: SEQUA, the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, today announces the publication of “Using the alfapump to control ascites enabling elective umbilical hernia repair: A case report” in the prestigious peer-reviewed journal, Hernia. The case study presented a patient from the POSEIDON study that received an alfapump for control of his ascites and subsequently underwent a robotic repair of his umbilical hernia. The publication is available online here.","length":643,"tagName":"p"},{"type":"text","content":"Dr. H.E. Vargas, M.D., Pro...